Document:

Unanimous Written Consent of Board of Managers

 Exhibit 10.4(a) 
  
 UNANIMOUS WRITTEN CONSENT 
 OF THE BOARD OF MANAGERS OF 
 RELIANT PHARMACEUTICALS, LLC 
  
 The undersigned, being all of the members of the Board of Managers (the
“Board”) of Reliant Pharmaceuticals, LLC, a Delaware limited liability company (the “Company”), in lieu of a meeting of the Board, and pursuant to the authority of Section 18-404(d) of the Delaware Limited Liability
Company Act, as amended and Section 8.5 of the Limited Liability Company Operating Agreement of the Company, hereby consent to, authorize and adopt the following resolutions with the same force and effect as if the undersigned were personally
present at a meeting of the Board and had voted for the same: 
  
 WHEREAS, this Company has adopted the Reliant Pharmaceuticals, LLC Equity Incentive Plan (the “Plan”); and 
  
 WHEREAS, the Plan may be amended by this Board at anytime; and 
  
 WHEREAS, it is desirable to amend the Plan. 
  
 NOW, THEREFORE, IT IS RESOLVED, that the Plan is hereby amended effective as of July 6, 2000, by deleting
Section 7(a) thereof in its entirety and substituting the following in lieu thereof: 
  
 “(a) The exercise price for the Units to be issued upon exercise of an Option shall be not less than the Fair Market Value of a Unit on the date the Option is granted.” 
  
 FURTHER RESOLVED, that the Plan shall be conformed to
reflect the amendment authorized hereby; 
  
 FURTHER RESOLVED, that the proper officers of the Company be, and each of them hereby is, authorized and directed to execute and deliver, in the name and on behalf of the Company, and any and all agreements, documents or instruments, and
take such actions as may be necessary or advisable to effect the intent of the resolutions set forth herein; 

 FURTHER RESOLVED, that for the purposes of these resolutions, the “proper
officers” of the Company shall be the Chairman of the Board, the Vice Chairman of the Board, the Chief Executive Officer, the President, any Vice President (regardless of designation), the Secretary, any Assistant Secretary and the Treasurer of
the Company; and 
  
 FURTHER RESOLVED, this
Consent may be executed in counterparts, each of which shall be deemed an original all of which, taken together, shall constitute one and the same instrument. 
  

(Signature page follows) 
  

 2 

 Dated as of November 13, 2001 
  

	
	 /s/ Jack L. Bowman

	 Jack L. Bowman

	
	 /s/ Herbert Conrad

	 Herbert Conrad

	
	 /s/ Fred B. Craves

	 Fred B. Craves

	
	 /s/ Joseph Krivulka

	 Joseph Krivulka

	
	 /s/ Irwin Lerner

	 Irwin Lerner

	
	 /s/ David V. Milligan

	 David V. Milligan

	
	 /s/ Gerald L. Cohn

	 Gerald L. Cohn

	
	 /s/ Mark S. Hoplamazian

	 Mark S. Hoplamazian

	
	 /s/ Thomas J. Pritzker

	 Thomas J. Pritzker

	
	 BEING ALL OF THE MEMBERS OF
 THE BOARD OF
MANAGERS OF
 RELIANT PHARMACEUTICALS, LLC

  

 3Unanimous Written Consent of the Board of Managers

 Exhibit 10.4(b) 
  
 UNANIMOUS WRITTEN CONSENT 
 OF THE BOARD OF MANAGERS OF 
 RELIANT PHARMACEUTICALS, LLC 
  
 The undersigned, being all of the members of the Board of Managers (the
“Board”) of Reliant Pharmaceuticals, LLC, a Delaware limited liability company (the “Company”), in lieu of a meeting of the Board, and pursuant to the authority of Section 18-404(d) of the Delaware Limited Liability
Company Act, as amended and Section 8.5 of the Second Amended and Restated Limited Liability Company Operating Agreement of the Company, hereby consent to, authorize and adopt the following resolutions with the same force and effect as if the
undersigned were personally present at a meeting of the Board and had voted for the same: 
  
 Amendment of Equity Plan 
  
 WHEREAS, this Company has adopted the Reliant Pharmaceuticals, LLC Equity Incentive Plan, as amended prior to the date hereof (the “Equity Plan”); and 
  
 WHEREAS, the Equity Plan may be amended by this Board at
anytime; and 
  
 WHEREAS, it is deemed desirable
to amend the Equity Plan to clarify that service with a parent of the Company, or subsidiary of the Company or a subsidiary of a parent company to the Company shall be treated as service with the Company for purposes of the Equity Plan. 

 
 RESOLVED, that the Equity Plan is hereby amended by
adding the following Section 19 thereto: 
  
 “19. Service with Parent or Subsidiaries. Notwithstanding anything contained herein to the contrary, employees of, consultants to and members of the board of directors or board of managers of any Parent (as defined below) or
Subsidiary (as defined below) shall be eligible to participate in this Plan, and shall be treated as a Service Provider under the Plan. All service with a Parent or Subsidiary shall count as service with the Company for purposes of vesting in any
Option and/or Restricted Unit. Transfer of employment or service as a consultant or manager from the Company to employee, consultant, manager or director of any Parent or Subsidiary shall not be treated as a termination as a Service Provider for any
purposes of the Plan and for so long as an individual provides services to the Company, a Parent or a Subsidiary, as an employee, consultant or manager or director in such capacity that if such services were being performed for the Company that such
individual would be treated as an Employee, 

 Consultant and Manager as defined in this Plan, then such individual shall continue to be a Service
Provider for all purposes of the Plan. For purposes of this Section 19, “Parent” shall mean any entity, whether now or hereafter existing (other than the Company) in an unbroken chain of entities ending with the Company if each of
the entities other than the last entity in the unbroken chain owns more than fifty percent of the total combined voting power of all equity securities in one of the other entities in such chain, and “Subsidiary” shall mean any
corporation, limited partnership, limited liability company or any other entity of which the Company or a Parent owns more than 50% of the voting stock or equity or a controlling interest.” 
  
 FURTHER RESOLVED, that the Equity Plan shall be conformed to
reflect the amendment authorized hereby. 
  

 2 

 General 
  
 FURTHER RESOLVED, that the proper officers of the Company be, and each of them hereby is, authorized and
directed to execute and deliver, in the name and on behalf of the Company, and any and all agreements, documents or instruments, and take such actions as may be necessary or advisable to effect the intent of the resolutions set forth herein;

  
 FURTHER RESOLVED, that for the purposes of
these resolutions, the “proper officers” of the Company shall be the Chairman of the Board, the Vice Chairman of the Board, the President, any Vice President (regardless of designation), the Secretary, any Assistant Secretary and the
Treasurer of the Company; and 
  
 FURTHER
RESOLVED, this Consent may be executed in counterparts, each of which shall be deemed an original all of which, taken together, shall constitute one and the same instrument. 
  
 (Signature page follows) 
  

 3 

 (Signature Page to Unanimous Written Consent amending Equity Incentive Plan) 
  
 Dated as of April 29, 2002 
  

	
	 /s/ Jack L. Bowman

	 Jack L. Bowman

	
	 /s/ Herbert Conrad

	 Herbert Conrad

	
	 /s/ Fred B. Craves

	 Fred B. Craves

	
	 /s/ Joseph Krivulka

	 Joseph Krivulka

	
	 /s/ Irwin Lerner

	 Irwin Lerner

	
	 /s/ David V. Milligan

	 David V. Milligan

	
	 /s/ Gerald L. Cohn

	 Gerald L. Cohn

	
	 /s/ Mark S. Hoplamazian

	 Mark S. Hoplamazian

	
	 /s/ Thomas J. Pritzker

	 Thomas J. Pritzker

	
	 /s/ Richard F. Pops

	 Richard F. Pops

	
	 BEING ALL OF THE MEMBERS OF
 THE BOARD OF
MANAGERS OF
 RELIANT PHARMACEUTICALS, LLC

  

 4Written Consent of the Board of Managers

 Exhibit 10.4(c) 
  
 WRITTEN CONSENT 
 OF THE BOARD OF MANAGERS OF 
 RELIANT PHARMACEUTICALS, LLC 
  
 The undersigned, being at least a majority of all of the members of the Board
of Managers (the “Board”) of Reliant Pharmaceuticals, LLC, a Delaware limited liability company (the “Company”), in lieu of a meeting of the Board, and pursuant to the authority of Section 18-404(d) of the Delaware
Limited Liability Company Act, as amended and Section 8.5 of the Second Amended and Restated Limited Liability Company Operating Agreement of the Company, hereby consent to, authorize and adopt the following resolutions with the same force and
effect as if the undersigned were personally present at a meeting of the Board and had voted for the same: 
  
 Amendment of Equity Plan 
  
 WHEREAS, the Company has adopted the Reliant Pharmaceuticals, LLC Equity Incentive Plan, as amended prior to the date hereof (the
“Equity Plan”); and 
  
 WHEREAS,
the Equity Plan may be amended by this Board at anytime; and 
  
 WHEREAS, it is deemed desirable to amend the Equity Plan to clarify that options, may if so provided in the agreement evidencing the grant of such option, continue to vest and be exercised following the termination of
the participant as a Service Provider, as defined in the Equity Plan. 
  
 RESOLVED, that the Equity Plan is hereby amended as follows: 
  
 1. By substituting the following for Section 8(a): 
  
 “(a) Vesting; Fractional Exercises. Options granted hereunder shall be vested and exercisable
according to the terms hereof at such times and under such conditions as determined by the Committee and set forth in the Option Agreement. Unless otherwise specifically provided in the Option Agreement, if, on the date of termination, the Holder is
not vested as to his or her entire Option, the Units covered by the unvested portion of the Option shall immediately cease to be issuable under the Option. An Option may not be exercised for a fraction of an Unit.” 

 2. By substituting the following for Section 8(d), (e) and (f): 
  
 “(d) Termination of Relationship as a Service
Provider. If the Participant ceases to be a Service Provider other than for Cause or by reason of the Participant’s Disability or death, the Holder of such Participant’s Options may exercise the Option within such period of time as is
specified in the Option Agreement (but in no event later than the expiration of the term of the Option as set forth in the Option Agreement). In the absence of a specified time in the Option Agreement, the Option shall remain exercisable for three
(3) months following the Participant’s termination. Unless otherwise specified in the Participant’s Option Agreement, Options may be exercised following termination as a Service Provider only to the extent vested on the date of
termination, and any portion of an Option in which the Participant is not vested upon such termination shall be forfeited and terminated. 
  
 (e) Disability of Participant. If a Participant ceases to be a Service Provider as a result of Disability, the Holder of such
Participant’s Option may exercise such Option within such period of time as is specified in the Option Agreement (but in no event later than the expiration of the term of such Option as set forth in the Option Agreement). In the absence of a
specified time in the Option Agreement, the Option shall remain exercisable for twelve (12) months following the Participant’s termination. Unless otherwise specified in the Participant’s Option Agreement, Options may be exercised
following termination as a Service Provider only to the extent vested on the date of termination, and any portion of an Option in which the Participant is not vested upon such termination shall be forfeited and terminated. 
  
 (f) Death of Participant. If a Participant dies while
a Service Provider, the Option may be exercised within such period of time as is specified in the Option Agreement by the executor of the Participant’s estate or by a person who acquires the right to exercise the Option by bequest, inheritance,
or the laws of descent or distribution. In the absence of a specified time in the Option Agreement, the Option shall remain exercisable for twelve (12) months following the Participant’s termination (but in no event later than the expiration of
the term of such Option as set forth in the Option Agreement). Unless otherwise specified in the Participant’s Option Agreement, Options may be exercised following termination as a Service Provider only to the extent vested on the date of
termination, and any portion of an Option in which the Participant is not vested upon such termination shall be forfeited and terminated.” 
  
 In all other respects the Equity Plan shall remain in full force and effect. 
  
 FURTHER RESOLVED, that the Equity Plan shall be conformed to
reflect the amendment authorized hereby. 
  
 General

  
 FURTHER RESOLVED, that the proper officers
of the Company be, and each of them hereby is, authorized and directed to execute and deliver, in the name and on behalf 
  

 2 

 of the Company, and any and all agreements, documents or instruments, and take such actions as may be
necessary or advisable to effect the intent of the resolutions set forth herein; 
  
 FURTHER RESOLVED, that for the purposes of these resolutions, the “proper officers” of the Company shall be the Chairman of the
Board, the Vice Chairman of the Board, the President, any Vice President (regardless of designation), the Secretary, any Assistant Secretary and the Treasurer of the Company; and 
  
 FURTHER RESOLVED, this Consent may be executed in counterparts, each of which shall be deemed an original
all of which, taken together, shall constitute one and the same instrument. 
  
 (Signature page follows) 
  

 3 

 (Signature Page to Written Consent amending Equity Incentive Plan) 
  
 Dated as of September 24, 2002 
  

	
	 /s/ Jack L. Bowman

	 Jack L. Bowman

	
	 /s/ Gerald L. Cohn

	 Gerald L. Cohn

	
	 /s/ Herbert Conrad

	 Herbert Conrad

	
	 /s/ Fred B. Craves

	 Fred B. Craves

	
	 /s/ Joseph Krivulka

	 Joseph Krivulka

	
	 /s/ Irwin Lerner

	 Irwin Lerner

	
	 /s/ Ernest Mario

	 Ernest Mario

	
	 /s/ David V. Milligan

	 David V. Milligan

	
	 /s/ Mark S. Hoplamazian

	 Mark S. Hoplamazian

	
	 /s/ Richard Pops

	 Richard Pops

	
	 /s/ Thomas J. Pritzker

	 Thomas J. Pritzker

	
	 BEING AT LEAST A MAJORITY OF
 ALL OF THE
MEMBERS OF THE
 BOARD OF MANAGERS OF RELIANT
 PHARMACEUTICALS, LLC

  

 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]